GPC Biotech AG (GPCB)

[surf1944]

GPC Biotech AG Earnings Conference Call (Q1 2008) Today's

Call Details
GPC Biotech AG Earnings Conference Call (Q1 2008)
Scheduled to start Thu, May 15, 2008, 8:00 am Eastern

Check back at the scheduled start time for
the audio link to appear in this spot.

Add this event to your Yahoo! Calendar Add This Event To Your Yahoo! Calendar

About GPC Biotech AG (NasdaqGM:GPCB)
GPC Biotech AG, a biopharmaceutical company, engages in the discovery, development, and commercialization of anticancer drugs in Germany. The company also develops genomics and proteomics technologies that comprises gene expression analysis, protein-protein interaction analysis, and bioinformatic tools, as well as provides related services. It focuses on oncology, immunology, and microbiology. The company’s lead product candidate includes satraplatin, a platinum-based compound for chemotherapy treatment in hormone-refractory prostate cancer. It also develops 1D09C3, a monoclonal antibody, which is in Phase I clinical trial for the treatment of lymphoid cancers, as well as has ongoing drug development and discovery programs that focuses on kinase inhibitors. The company has an agreement with ALTANA Pharma to license its proprietary drug-protein interaction technology, LeadCode. GPC Biotech AG was founded in 1997 and is headquartered in Munich, Germany.

http://biz.yahoo.com/cc/8/93068.html